Back

Molecular cloning of a novel, nervous system-specific RGS6 isoform lacking canonical G protein regulatory effects and with dominant negative actions

Dannen, K. E.; Yang, J.; Bernholtz, J.; Glebov-McCloud, A.; Strack, S.; Koland, J. G.; Fisher, R. A.; Stewart, A.

2026-05-12 neuroscience
10.64898/2026.05.08.723811 bioRxiv
Show abstract

Regulator of G protein Signaling 6 (RGS6), heavily implicated in neurological and neuropsychiatric disorders, is enriched in mouse and human brain. Our initial cloning effort identified 36 RGS6 mRNAs in human brain. However, we recently identified an additional RGS6 protein isoform that is larger ([~]69kDa) than the ubiquitously expressed [~]56kDa RGS6L(+GGL) isoforms. Notably, this isoform, named "RGS6B" for "brain-specific", is selectively expressed in the nervous system of mice and humans. Here, we report the cloning of a new RGS6-encoding mRNA, which resembles the RGS6L1(+GGL) transcript identified in our initial cloning effort but includes a highly conserved novel exon (Alternative 3, A3) that alters the reading frame of terminal exon resulting in an extension of the protein C-terminus. When expressed in cells, RGS6LA31(+GGL) co-migrates with RGS6B, and, importantly, interfering RNA targeting exon A3 results in selective depletion of RGS6B in isolated primary cortical astrocytes. RGS6B is capable of stabilizing RGS6 binding partners R7BP and G{beta}5 and, in fact, exhibits an increased protein half-life relative to RGS6L. Both RGS6L and RGS6B are downregulated in human gliomas and share the ability to kill U87MG glioblastoma cells when overexpressed indicating conservation of non-canonical cytotoxic activity between RGS6L and RGS6B species. However, RGS6B lacks the ability to counteract Gi/o-dependent suppression of cAMP signaling, indicating a lack of functional GTPase activating protein (GAP) activity. Instead, RGS6B functions in a dominant negative manner to block Gi/o regulation by RGS6L. RGSB is the first identified RGS protein member that functions to promote, rather than inhibit, G protein signaling. The discovery of the molecular identity of RGS6B will now allow for delineation of unique functions for RGS6 protein isoforms in both physiological and pathophysiological brain states.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 14%
12.5%
2
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 10%
6.9%
3
Cell Reports
1338 papers in training set
Top 9%
4.9%
4
Journal of Biological Chemistry
641 papers in training set
Top 0.3%
4.3%
5
Scientific Reports
3102 papers in training set
Top 30%
4.0%
6
International Journal of Molecular Sciences
453 papers in training set
Top 2%
3.9%
7
eLife
5422 papers in training set
Top 24%
3.7%
8
PLOS Genetics
756 papers in training set
Top 5%
3.3%
9
Brain
154 papers in training set
Top 2%
3.3%
10
Human Molecular Genetics
130 papers in training set
Top 1%
2.6%
11
iScience
1063 papers in training set
Top 9%
2.4%
50% of probability mass above
12
eneuro
389 papers in training set
Top 4%
2.1%
13
Cell Reports Medicine
140 papers in training set
Top 3%
2.1%
14
Life Science Alliance
263 papers in training set
Top 0.1%
2.1%
15
The Journal of Neuroscience
928 papers in training set
Top 5%
1.9%
16
The American Journal of Human Genetics
206 papers in training set
Top 2%
1.7%
17
PLOS ONE
4510 papers in training set
Top 53%
1.7%
18
EMBO Molecular Medicine
85 papers in training set
Top 2%
1.7%
19
Nature
575 papers in training set
Top 12%
1.5%
20
Science Advances
1098 papers in training set
Top 23%
1.2%
21
Cells
232 papers in training set
Top 4%
1.2%
22
Journal of Clinical Investigation
164 papers in training set
Top 4%
1.2%
23
Molecular Therapy
71 papers in training set
Top 2%
0.9%
24
Nucleic Acids Research
1128 papers in training set
Top 16%
0.8%
25
Molecular Neurodegeneration
49 papers in training set
Top 0.8%
0.8%
26
Acta Neuropathologica
51 papers in training set
Top 1%
0.8%
27
Communications Biology
886 papers in training set
Top 23%
0.8%
28
Journal of Experimental Medicine
106 papers in training set
Top 4%
0.8%
29
Journal of Cell Science
353 papers in training set
Top 2%
0.7%
30
Nature Genetics
240 papers in training set
Top 8%
0.7%